Literature DB >> 8015131

Ethics, economics, and the publication policies of major medical journals.

K Schulman1, D P Sulmasy, D Roney.   

Abstract

OBJECTIVE: To evaluate aspects of the publication process that may affect the quality of the literature in clinical economics and biomedical ethics, and to learn about the policies of medical journals regarding disclosure of relationships between investigators and research sponsors.
DESIGN: Mail survey. PARTICIPANTS: Editors in chief of 15 major medical journals.
RESULTS: Twelve editors responded to the survey. Ten reported having statisticians among their editors, while only two had health economists and none had ethicists. Clinicians in the specialty field were almost always the primary reviewers of submissions, while methodologists (statisticians, health economists, or ethicists) were involved less frequently. Journals reported little knowledge of the training of their reviewers in these fields. While nine journals requested disclosure of the financial relationship between author and sponsor, only one inquired whether the sponsor's written approval was required prior to manuscript submission, and only one knew whether there was an independent steering committee for the study.
CONCLUSIONS: These findings suggest that the peer review process can be strengthened to improve the quality of the medical literature in clinical economics and biomedical ethics. Journal editors also need to better understand the terms of research sponsorship agreements.

Entities:  

Keywords:  Bioethics and Professional Ethics; Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  1994        PMID: 8015131

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  8 in total

1.  A reappraisal of economic evaluation of pharmaceuticals. Science or marketing?

Authors:  M F Drummond
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

2.  Applied pharmacoeconomics. When can publication be legitimately withheld?

Authors:  G C Yee; A L Hillman
Journal:  Pharmacoeconomics       Date:  1997-11       Impact factor: 4.981

3.  Relationship between conflicts of interest and research results.

Authors:  Lee S Friedman; Elihu D Richter
Journal:  J Gen Intern Med       Date:  2004-01       Impact factor: 5.128

Review 4.  Relationships between sponsors and investigators in pharmacoeconomic and clinical research.

Authors:  K A Schulman; L E Rubenstein; H A Glick; J M Eisenberg
Journal:  Pharmacoeconomics       Date:  1995-03       Impact factor: 4.981

5.  Assessing quality of economic submissions to the BMJ.

Authors:  T Jefferson; V Demicheli; V Entwistle
Journal:  BMJ       Date:  1995-08-05

6.  Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

Authors:  M F Drummond; T O Jefferson
Journal:  BMJ       Date:  1996-08-03

7.  Guardians of the lamp.

Authors:  D R Goldmann
Journal:  J Gen Intern Med       Date:  1995-08       Impact factor: 5.128

8.  The relationship of previous training and experience of journal peer reviewers to subsequent review quality.

Authors:  Michael L Callaham; John Tercier
Journal:  PLoS Med       Date:  2007-01       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.